Skip to main content
SpringerLink
Log in
Book cover

Clinical Trials in Rheumatoid Arthritis and Osteoarthritis pp 275–287Cite as

Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis

  • Chapter

  • 1229 Accesses

Part of the book series: Clinical Trials ((CLINICAL))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Leppavuori J, Kujala U, Kinnunen J et al. Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q. Am J Hum Genet 1999, 65:1060–1067.

    Article  PubMed  CAS  Google Scholar 

  2. Nyholt DR. All LODs are not created equal. Am J Hum Genet 2000, 67:282–288.

    Article  PubMed  CAS  Google Scholar 

  3. Chapman K, Mustafa Z, Irven C et al. Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet 1999, 65:167–174.

    Article  PubMed  CAS  Google Scholar 

  4. Ingvarsson T, Stefansson SE, Gulcher JR et al. A large Icelandic family with early osteoarthritis of the hip associated with a susceptibility locus on chromosome 16p. Arthritis Rheum 2001, 44:2548–2555.

    Article  PubMed  CAS  Google Scholar 

  5. Demissie S, Cupples LA, Myers R et al. Genome scan for quantity of hand osteoarthritis: the Framingham Study. Arthritis Rheum 2002, 46:946–952.

    Article  PubMed  CAS  Google Scholar 

  6. MacKay K, Eyre S, Myerscough A et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 2002, 46:632–639.

    Article  PubMed  CAS  Google Scholar 

  7. Bacanu SA, Devlin B, Roeder K. Association studies for quantitative traits in structured populations. Genet Epidemiol 2002, 22:78–93.

    Article  PubMed  Google Scholar 

  8. Newton J, Brown MA, Milicic A et al. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum 2003, 48:90–96.

    Article  PubMed  CAS  Google Scholar 

  9. Carlson CS, Eberle MA, Kruglyak L et al. Mapping complex disease loci in whole-genome association studies. Nature 2004, 429:446–452.

    Article  PubMed  CAS  Google Scholar 

  10. The International HapMap Project. Nature 2003, 426:789–796.

    Google Scholar 

  11. Carlson CS, Eberle MA, Rieder MJ et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74:106–120.

    Article  PubMed  CAS  Google Scholar 

  12. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995, 57:455–464.

    PubMed  CAS  Google Scholar 

  13. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000, 66:279–292.

    Article  PubMed  CAS  Google Scholar 

  14. Abecasis GR, Cookson WO, Cardon LR. Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000, 8:545–551.

    Article  PubMed  CAS  Google Scholar 

  15. Nadeau JH, Singer JB, Matin A et al. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 2000, 24:221–225.

    Article  PubMed  CAS  Google Scholar 

  16. Barton A, Eyre S, Myerscough A et al. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Hum Mol Genet 2001, 10:1901–1906.

    Article  PubMed  CAS  Google Scholar 

  17. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004, 429:464–468.

    Article  PubMed  CAS  Google Scholar 

  18. Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:89–104.

    Article  PubMed  CAS  Google Scholar 

  19. Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003, 100:10393–10398.

    Article  PubMed  CAS  Google Scholar 

  20. Cheok MH, Yang W, Pui CH et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 2003, 34:85–90.

    Article  PubMed  CAS  Google Scholar 

  21. Stegmaier K, Ross KN, Colavito SA et al. Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet 2004, 36:257–263.

    Article  PubMed  CAS  Google Scholar 

  22. Loughlin J. Genetic epidemiology of primary osteoarthritis. Curr Opin Rheumatol 2001, 13:111–116.

    Article  PubMed  CAS  Google Scholar 

  23. Smith AJ, Keen LJ, Billingham MJ et al. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis. Genes Immun 2004;5:451–460.

    Article  PubMed  CAS  Google Scholar 

  24. Loughlin J, Dowling B, Mustafa Z et al. Association of the interleukin-1 gene cluster on chromosome 2q13 with knee osteoarthritis. Arthritis Rheum 2002, 46:1519–1527.

    Article  PubMed  CAS  Google Scholar 

  25. Stefansson SE, Jonsson H, Ingvarsson T et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am J Hum Genet 2003, 72:1448–1459.

    Article  PubMed  CAS  Google Scholar 

  26. Loughlin J, Dowling B, Chapman K et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A 2004, 101:9757–9762.

    Article  PubMed  CAS  Google Scholar 

  27. Forster T, Chapman K, Loughlin J. Common variants within the interleukin 4 receptor alpha gene (IL4R) are associated with susceptibility to osteoarthritis. Hum Genet 2004, 114:391–395.

    Article  PubMed  CAS  Google Scholar 

  28. Uitterlinden AG, Burger H, Huang Q et al. Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J Clin Invest 1997, 100:259–263.

    Article  PubMed  CAS  Google Scholar 

  29. Uitterlinden AG, Burger H, van Duijn CM et al. Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee. Arthritis Rheum 2000, 43:1456–1464.

    Article  PubMed  CAS  Google Scholar 

  30. Bergink AP, van Meurs JB, Loughlin J et al. Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women. Arthritis Rheum 2003, 48:1913–1922.

    Article  PubMed  CAS  Google Scholar 

  31. Cooper C, Inskip H, Croft P et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 1998, 147:516–522.

    PubMed  CAS  Google Scholar 

  32. Croft P, Coggon D, Cruddas M et al. Osteoarthritis of the hip: an occupational disease in farmers. Br Med J 1992, 304:1269–1272.

    Article  CAS  Google Scholar 

  33. Aspden RM, Scheven BA, Hutchison JD. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001, 357:1118–1120.

    Article  PubMed  CAS  Google Scholar 

  34. Wordsworth BP, Lanchbury JS, Sakkas LI et al. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989, 86:10049–10053.

    Article  PubMed  CAS  Google Scholar 

  35. Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996, 59:676–683.

    PubMed  CAS  Google Scholar 

  36. Barton A, John S, Ollier WE et al. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001, 44:61–65.

    Article  PubMed  CAS  Google Scholar 

  37. Yamada R, Tanaka T, Unoki M et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001, 68:674–685.

    Article  PubMed  CAS  Google Scholar 

  38. Eskdale J, McNicholl J, Wordsworth P et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998, 352:1282–1283.

    Article  PubMed  CAS  Google Scholar 

  39. Buchs N, Silvestri T, Di Giovine FS et al. IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxford) 2000, 39:1126–1131.

    Article  CAS  Google Scholar 

  40. Elliott MJ, Maini RN, Feldmann M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993, 36:1681–1690.

    Article  PubMed  CAS  Google Scholar 

  41. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998, 41:2196–2204.

    Article  PubMed  CAS  Google Scholar 

  42. Yates CR, Krynetski EY, Loennechen T et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997, 126:608–614.

    PubMed  CAS  Google Scholar 

  43. Black AJ, McLeod HL, Capell HA et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 1998, 129:716–718.

    PubMed  CAS  Google Scholar 

  44. Marra CA, Esdaile JM, Anis AH. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol 2002, 29:2507–2512.

    PubMed  Google Scholar 

  45. Brennan F, Chantry D, Jackson A et al. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989, ii:244–247.

    Article  Google Scholar 

  46. Padyukov L, Lampa J, Heimburger M et al. Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis 2003, 62:526–529.

    Article  PubMed  CAS  Google Scholar 

  47. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000, 405:857–865.

    Article  PubMed  CAS  Google Scholar 

  48. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004, 329:15–19.

    Article  Google Scholar 

  49. Bentley DR. Genomes for medicine. Nature 2004, 429:440–445.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head of School of Molecular and Clinical Medicine & arc Professor of Rheumatology, Molecular Medicine Centre, University of Edinburgh, Edinburgh, UK

    Stuart H. Ralston

Authors
  1. Stuart H. Ralston
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK

    David M. Reid MBChB, MD, FRCP

  2. Bio-Imaging Technologies Inc, Newtown, PA, USA

    Colin G. Miller BSc, PhD, FICR

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Ralston, S.H. (2008). Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis. In: Reid, D.M., Miller, C.G. (eds) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-742-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-742-8_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-874-9

  • Online ISBN: 978-1-84628-742-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation